Search Ontology:
ChEBI
arformoterol
- Term ID
- CHEBI:408174
- Synonyms
-
- (-)-formoterol
- (R,R)-formoterol
- arformoterol
- N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide
- Definition
- An N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide in which both of the stereocentres have R configuration. The active enantiomer of formoterol, it is administered by inhalation (generally as the tartrate salt) as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).
- References
-
- Beilstein:7861827
- CAS:67346-49-0
- DrugBank:DB01274
- Drug_Central:4943
- KEGG:D07463
- PMID:15324892
- PMID:18990965
- PMID:20214460
- PMID:20406080
- Patent:US2011014246
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse has_part
-
- inverse is_conjugate_acid_of
-
- inverse is_enantiomer_of
-
- is_conjugate_base_of
-
- is_enantiomer_of
-
Phenotype
Phenotype resulting from arformoterol
Phenotype where environments contain arformoterol
Phenotype modified by environments containing arformoterol
Human Disease / Model Data